Learning from Leprosy. Insight into the human innate immune response

Advances in Immunology

Volumn 105, Issue C, 2010, Pages 1-24

  Montoya, Dennis ^a   Modlin, Robert L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PATTERN RECOGNITION RECEPTOR; VITAMIN D; CYTOKINE;

ARTICLE; CELL DIFFERENTIATION; CYTOKINE RESPONSE; DENDRITIC CELL; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFECTION; INNATE IMMUNITY; LEPROSY; MACROPHAGE; MYCOBACTERIUM LEPRAE; PRIORITY JOURNAL; TISSUE INJURY; GENETICS; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; REVIEW;

CYTOKINES; HUMANS; IMMUNITY, INNATE; LEPROSY; MYCOBACTERIUM LEPRAE; RECEPTORS, PATTERN RECOGNITION;

EID: 77955946634     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/S0065-2776(10)05001-7     Document Type: Chapter

References (135)

1. Aliprantis A.O., Yang R.-B., Mark M.R., Suggett S., Devaux B., Radolf J.D., Klimpel G.R., Godowski P., Zychlinsky A. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 1999, 285:736-739.
2. Almeida P.E., Silva A.R., Maya-Monteiro C.M., Torocsik D., D'Avila H., Dezso B., Magalhaes K.G., Castro-Faria-Neto H.C., Nagy L., Bozza P.T. Mycobacterium bovis bacillus Calmette-Guerin infection induces TLR2-dependent peroxisome proliferator-activated receptor gamma expression and activation: Functions in inflammation, lipid metabolism, and pathogenesis. J. Immunol. 2009, 183:1337-1345.
3. Alonso S., Pethe K., Russell D.G., Purdy G.E. Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc. Natl. Acad. Sci. USA 2007, 104:6031-6036.
4. Austin C.M., Ma X., Graviss E.A. Common nonsynonymous polymorphisms in the NOD2 gene are associated with resistance or susceptibility to tuberculosis disease in African Americans. J. Infect. Dis. 2008, 197:1713-1716.
5. Bafica A., Scanga C.A., Feng C.G., Leifer C., Cheever A., Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J. Exp. Med. 2005, 202:1715-1724.
6. Bakker M.I., Hatta M., Kwenang A., Klatser P.R., Oskam L. Epidemiology of leprosy on five isolated islands in the Flores Sea, Indonesia. Trop. Med. Int. Health 2002, 7:780-787.
7. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
8. Baumgart K.W., Britton W.J., Mullins R.J., Basten A., Barnetson R.S. Subclinical infection with Mycobacterium leprae-A problem for leprosy control strategies. Trans. R. Soc. Trop. Med. Hyg. 1993, 87:412-415.
9. Beckman E.M., Porcelli S.A., Morita C.T., Behar S.M., Furlong S.T., Brenner M.B. Recognition of a lipid antigen by CD1-restricted αβ+ T cells. Nature 1994, 372:691-694.
10. Bleharski J.R., Li H., Meinken C., Graeber T.G., Ochoa M.T., Yamamura M., Burdick A., Sarno E.N., Wagner M., Rollinghoff M., Rea T.H., Colonna M., et al. Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science 2003, 301:1527-1530.
11. Bloom B.R. Learning from leprosy: A perspective on immunology and the third world. J. Immunol. 1986, 137:i-x.
12. Blumenthal A., Kobayashi T., Pierini L.M., Banaei N., Ernst J.D., Miyake K., Ehrt S. RP105 facilitates macrophage activation by Mycobacterium tuberculosis lipoproteins. Cell Host Microbe 2009, 5:35-46.
13. Bochud P.Y., Hawn T.R., Aderem A. Cutting edge: A Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J. Immunol. 2003, 170:3451-3454.
14. Bochud P.Y., Sinsimer D., Aderem A., Siddiqui M.R., Saunderson P., Britton S., Abraham I., Tadesse A.A., Janer M., Hawn T.R., Kaplan G. Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28:1055-1065.
15. Bockle B.C., Solder E., Kind S., Romani N., Sepp N.T. DC-sign+ CD163+ macrophages expressing hyaluronan receptor LYVE-1 are located within chorion villi of the placenta. Placenta 2008, 29:187-192.
16. Bowdish D.M., Sakamoto K., Kim M.J., Kroos M., Mukhopadhyay S., Leifer C.A., Tryggvason K., Gordon S., Russell D.G. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog. 2009, 5:e1000474.
17. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., Maitland M., Norgard M.V., Plevy S.E., Smale S.T., Brennan P.J., Bloom B.R., et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 1999, 285:732-736.
18. Britton W.J., Lockwood D.N. Leprosy. Lancet 2004, 363:1209-1219.
19. Bulut Y., Michelsen K.S., Hayrapetian L., Naiki Y., Spallek R., Singh M., Arditi M. Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals. J. Biol. Chem. 2005, 280:20961-20967.
20. Cardona P.J., Llatjos R., Gordillo S., Diaz J., Ojanguren I., Ariza A., Ausina V. Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis. Scand. J. Immunol. 2000, 52:156-163.
21. Cole S.T., Eiglmeier K., Parkhill J., James K.D., Thomson N.R., Wheeler P.R., Honore N., Garnier T., Churcher C., Harris D., Mungall K., Basham D., et al. Massive gene decay in the leprosy bacillus. Nature 2001, 409:1007-1011.
22. Cooper C.L., Mueller C., Sinchaisri T.-A., Pirmez C., Chan J., Kaplan G., Young S.M.M., Weissman I.L., Bloom B.R., Rea T.H., Modlin R.L. Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J. Exp. Med. 1989, 169:1565-1581.
23. Cruz D., Watson A.D., Miller C.S., Montoya D., Ochoa M.T., Sieling P.A., Gutierrez M.A., Navab M., Reddy S.T., Witztum J.L., Fogelman A.M., Rea T.H., et al. Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J. Clin. Invest. 2008, 118:2917-2928.
24. Cywes C., Godenir N.L., Hoppe H.C., Scholle R.R., Steyn L.M., Kirsch R.E., Ehlers M.R. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells. Infect. Immun. 1996, 64:5373-5383.
25. D'Avila H., Melo R.C., Parreira G.G., Werneck-Barroso E., Castro-Faria-Neto H.C., Bozza P.T. Mycobacterium bovis bacillus Calmette-Guerin induces TLR2-mediated formation of lipid bodies: Intracellular domains for eicosanoid synthesis in vivo. J. Immunol. 2006, 176:3087-3097.
26. Davila S., Hibberd M.L., Hari D.R., Wong H.E., Sahiratmadja E., Bonnard C., Alisjahbana B., Szeszko J.S., Balabanova Y., Drobniewski F., van Crevel R., van de Vosse E., et al. Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis. PLoS Genet. 2008, 4:e1000218.
27. Delbridge L.M., O'Riordan M.X. Innate recognition of intracellular bacteria. Curr. Opin. Immunol. 2007, 19:10-16.
28. Divangahi M., Mostowy S., Coulombe F., Kozak R., Guillot L., Veyrier F., Kobayashi K.S., Flavell R.A., Gros P., Behr M.A. NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J. Immunol. 2008, 181:7157-7165.
29. Durrheim D.N., Fourie A., Balt E., Le R.M., Harris B.N., Matebula M., De Villiers M., Speare R. Leprosy in Mpumalanga province, South Africa-Eliminated or hidden?. Lepr. Rev. 2002, 73:326-333.
30. Fabriek B.O., Van Haastert E.S., Galea I., Polfliet M.M., Dopp E.D., Van den Heuvel M.M., Van den Berg T.K., De Groot C.J., Van der Valk P., Dijkstra C.D. CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation. Glia 2005, 51:297-305.
31. Ferwerda G., Girardin S.E., Kullberg B.J., Le B.L., de Jong D.J., Langenberg D.M., van Crevel R., Adema G.J., Ottenhoff T.H., Van der Meer J.W., Netea M.G. NOD2 and Toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog. 2005, 1:279-285.
32. Fitness J., Floyd S., Warndorff D.K., Sichali L., Mwaungulu L., Crampin A.C., Fine P.E., Hill A.V. Large-scale candidate gene study of leprosy susceptibility in the Karonga district of northern Malawi. Am. J. Trop. Med. Hyg. 2004, 71:330-340.
33. Florey H. Tuberculosis. General pathology, based on lectures delivered at the Sir William Dunn School of Pathology 1958, 829-870. W.B. Saunders, Philadelphia, University of Oxford. H. Florey (Ed.).
34. Franceschi D.S., Mazini P.S., Rudnick C.C., Sell A.M., Tsuneto L.T., Ribas M.L., Peixoto P.R., Visentainer J.E. Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil. Int. J. Infect. Dis. 2009, 13:493-498.
35. Fratti R.A., Chua J., Vergne I., Deretic V. Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc. Natl. Acad. Sci. USA 2003, 100:5437-5442.
36. Gandotra S., Jang S., Murray P.J., Salgame P., Ehrt S. Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis. Infect. Immun. 2007, 75:5127-5134.
37. Gao B., Tsan M.F. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J. Biol. Chem. 2003, 278:174-179.
38. Garcia V.E., Uyemura K., Sieling P.A., Ochoa M.T., Morita C.T., Okamura H., Kurimoto M., Rea T.H., Modlin R.L. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. J. Immunol. 1999, 162:6114-6121.
39. Gehring A.J., Dobos K.M., Belisle J.T., Harding C.V., Boom W.H. Mycobacterium tuberculosis LprG (Rv1411c): A novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. J. Immunol. 2004, 173:2660-2668.
40. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 2003, 278:8869-8872.
41. Goulart L.R., Ferreira F.R., Goulart I.M. Interaction of TaqI polymorphism at exon 9 of the vitamin D receptor gene with the negative lepromin response may favor the occurrence of leprosy. FEMS Immunol. Med. Microbiol. 2006, 48:91-98.
42. Grange J.M., Davies P.D., Brown R.C., Woodhead J.S., Kardjito T. A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. Tubercle 1985, 66:187-191.
43. Greaves D.R., Gordon S. The macrophage scavenger receptor at 30 years of age-Current knowledge and future challenges. J. Lipid Res. 2009, 50:S282-S286.
44. Gunn F.D. Tuberculosis. Pathology 1961, 243-263. C.V. Mosby Company, St. Louis. W.A.D. Anderson (Ed.).
45. Gutierrez M.G., Master S.S., Singh S.B., Taylor G.A., Colombo M.I., Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004, 119:753-766.
46. Hamann L., Kumpf O., Schuring R.P., Alpsoy E., Bedu-Addo G., Bienzle U., Oskam L., Mockenhaupt F.P., Schumann R.R. Low frequency of the TIRAP S180L polymorphism in Africa, and its potential role in malaria, sepsis, and leprosy. BMC Med. Genet. 2009, 10:65.
47. Hernandez-Pando R., Pavon L., Arriaga K., Orozco H., Madrid-Marina V., Rook G. Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection. Infect. Immun. 1997, 65:3317-3327.
48. Jain M., Petzold C.J., Schelle M.W., Leavell M.D., Mougous J.D., Bertozzi C.R., Leary J.A., Cox J.S. Lipidomics reveals control of Mycobacterium tuberculosis virulence lipids via metabolic coupling. Proc. Natl. Acad. Sci. USA 2007, 104:5133-5138.
49. Johnson C.M., Lyle E.A., Omueti K.O., Stepensky V.A., Yegin O., Alpsoy E., Hamann L., Schumann R.R., Tapping R.I. Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J. Immunol. 2007, 178:7520-7524.
50. Jullien D., Sieling P.A., Uyemura K., Mar N.D., Rea T.H., Modlin R.L. IL-15, an immunomodulator of T cell responses in intracellular infection. J. Immunol. 1997, 158:800-806.
51. Kang B.K., Schlesinger L.S. Characterization of mannose receptor-dependent phagocytosis mediated by Mycobacterium tuberculosis lipoarabinomannan. Infect. Immun. 1998, 66:2769-2777.
52. Kang T.J., Chae G.T. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol. Med. Microbiol. 2001, 31:53-58.
53. Kang T.J., Lee S.B., Chae G.T. A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy. Cytokine 2002, 20:56-62.
54. Kang T.J., Yeum C.E., Kim B.C., You E.Y., Chae G.T. Differential production of interleukin-10 and interleukin-12 in mononuclear cells from leprosy patients with a Toll-like receptor 2 mutation. Immunology 2004, 112:674-680.
55. Kondo E., Kanai K. Further studies on the increase in cholesterol ester content of the lungs of tuberculous mice. Jpn. J. Med. Sci. Biol. 1974, 27:59-65.
56. Kondo E., Kanai K. Accumulation of cholesterol esters in macrophages incubated with mycobacteria in vitro. Jpn. J. Med. Sci. Biol. 1976, 29:123-137.
57. Korf J., Stoltz A., Verschoor J., De Baetselier P., Grooten J. The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses. Eur. J. Immunol. 2005, 35:890-900.
58. Krutzik S.R., Ochoa M.T., Sieling P.A., Uematsu S., Ng Y.W., Legaspi A., Liu P.T., Cole S.T., Godowski P.J., Maeda Y., Sarno E.N., Norgard M.V., et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat. Med. 2003, 9:525-532.
59. Krutzik S.R., Tan B., Li H., Ochoa M.T., Liu P.T., Sharfstein S.E., Graeber T.G., Sieling P.A., Liu Y.J., Rea T.H., Bloom B.R., Modlin R.L. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 2005, 11:653-660.
60. Krutzik S.R., Hewison M., Liu P.T., Robles J.A., Stenger S., Adams J.S., Modlin R.L. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J. Immunol. 2008, 181:7115-7120.
61. Leber J.H., Crimmins G.T., Raghavan S., Meyer-Morse N.P., Cox J.S., Portnoy D.A. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog. 2008, 4:e6.
62. Lee D.J., Sieling P.A., Ochoa M.T., Krutzik S.R., Guo B., Hernandez M., Rea T.H., Cheng G., Colonna M., Modlin R.L. LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells. J. Immunol. 2007, 179:8128-8136.
63. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., Kamen D.L., Wagner M., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
64. Liu P.T., Stenger S., Tang D.H., Modlin R.L. Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 2007, 179:2060-2063.
65. Liu P.T., Schenk M., Walker V.P., Dempsey P.W., Kanchanapoomi M., Wheelwright M., Vazirnia A., Zhang X., Steinmeyer A., Zugel U., Hollis B.W., Cheng G., et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One 2009, 4:e5810.
66. Maeda N., Nigou J., Herrmann J.L., Jackson M., Amara A., Lagrange P.H., Puzo G., Gicquel B., Neyrolles O. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J. Biol. Chem. 2003, 278:5513-5516.
67. Maeda Y., Mukai T., Spencer J., Makino M. Identification of an Immunomodulating Agent from Mycobacterium leprae. Infect. Immun. 2005, 73:2744-2750.
68. Malhotra D., Darvishi K., Sood S., Sharma S., Grover C., Relhan V., Reddy B.S., Bamezai R.N. IL-10 promoter single nucleotide polymorphisms are significantly associated with resistance to leprosy. Hum. Genet. 2005, 118:295-300.
69. Malhotra D., Relhan V., Reddy B.S., Bamezai R. TLR2 Arg677Trp polymorphism in leprosy: Revisited. Hum. Genet. 2005, 116:413-415.
70. Marincek B.C., Kuhnle M.C., Srokowski C., Schild H., Hammerling G., Momburg F. Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion. Mol. Immunol. 2008, 46:181-191.
71. Martineau A.R., Wilkinson K.A., Newton S.M., Floto R.A., Norman A.W., Skolimowska K., Davidson R.N., Sorensen O.E., Kampmann B., Griffiths C.J., Wilkinson R.J. IFN-γ- and TNF-independent vitamin D-inducible human suppression of mycobacteria: The role of Cathelicidin LL-37. J. Immunol. 2007, 178:7190-7198.
72. Martin-Fontecha A., Sebastiani S., Hopken U.E., Uguccioni M., Lipp M., Lanzavecchia A., Sallusto F. Regulation of dendritic cell migration to the draining lymph node: Impact on T lymphocyte traffic and priming. J. Exp. Med. 2003, 198:615-621.
73. Means T.K., Wang S., Lien E., Yoshimura A., Golenbock D.T., Fenton M.J. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 1999, 163:3920-3927.
74. Mechnikov I. On the present state of the question of immunity in infectious diseases. Nobel Lecture 1908, 12-11-1908.
75. Metchnikoff E. Ueber eine Sprosspilzkrankheit der Daphnien. Beitrag zur Lehre uber den Kampf der Phagocyten gegen Krankheitserrenger. Arch. Pathol. Anat. Physiol. Klin. Med. 1884, 96:177-195.
76. Miranda A., Amadeu T.P., Schueler G., Alvarenga F.B., Duppre N., Ferreira H., Nery J.A., Sarno E.N. Increased Langerhans cell accumulation after mycobacterial stimuli. Histopathology 2007, 51:649-656.
77. Misch E.A., Macdonald M., Ranjit C., Sapkota B.R., Wells R.D., Siddiqui M.R., Kaplan G., Hawn T.R. Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction. PLoS Negl. Trop. Dis. 2008, 2:e231.
78. Modlin R.L. The innate immune response in leprosy. Curr. Opin. Immunol. 2010, 10.1016/j.coi.2009.12.001.
79. Modlin R.L., Hofman F.M., Taylor C.R., Rea T.H. T lymphocyte subsets in the skin lesions of patients with leprosy. J. Am. Acad. Dermatol. 1983, 8:182-189.
80. Montoya D., Cruz D., Teles R.M., Lee D.J., Ochoa M.T., Krutzik S.R., Chun R., Schenk M., Zhang X., Ferguson B.G., Burdick A.E., Sarno E.N., et al. Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe 2009, 6:343-353.
81. Moody D.B., Porcelli S.A. Intracellular pathways of CD1 antigen presentation. Nat. Rev. Immunol. 2003, 3:11-22.
82. Moraes M.O., Pacheco A.G., Schonkeren J.J., Vanderborght P.R., Nery J.A., Santos A.R., Moraes M.E., Moraes J.R., Ottenhoff T.H., Sampaio E.P., Huizinga T.W., Sarno E.N. Interleukin-10 promoter single-nucleotide polymorphisms as markers for disease susceptibility and disease severity in leprosy. Genes Immun. 2004, 5:592-595.
83. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
84. Munoz-Elias E.J., McKinney J.D. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med. 2005, 11:638-644.
85. Murray R.A., Siddiqui M.R., Mendillo M., Krahenbuhl J., Kaplan G. Mycobacterium leprae inhibits dendritic cell activation and maturation. J. Immunol. 2007, 178:338-344.
86. Navab M., Ananthramaiah G.M., Reddy S.T., Van Lenten B.J., Ansell B.J., Fonarow G.C., Vahabzadeh K., Hama S., Hough G., Kamranpour N., Berliner J.A., Lusis A.J., et al. The oxidation hypothesis of atherogenesis: The role of oxidized phospholipids and HDL. J. Lipid Res. 2004, 45:993-1007.
87. Ochoa M.T., Loncaric A., Krutzik S.R., Becker T.C., Modlin R.L. " Dermal dendritic cells" comprise two distinct populations: CD1+ dendritic cells and CD209+ macrophages. J. Invest. Dermatol. 2008, 10.1038/jid.2008.56.
88. Oliveira R.B., Ochoa M.T., Sieling P.A., Rea T.H., Rambukkana A., Sarno E.N., Modlin R.L. Expression of Toll-like receptor 2 on human Schwann Cells: A mechanism of nerve damage in leprosy. Infect. Immun. 2003, 71:1427-1433.
89. Omueti K.O., Mazur D.J., Thompson K.S., Lyle E.A., Tapping R.I. The polymorphism P315L of human toll-like receptor 1 impairs innate immune sensing of microbial cell wall components. J. Immunol. 2007, 178:6387-6394.
90. Osler W. Tuberculosis. The principles and practice of medicine 1892, 184-255. D. Appleton and Company, New York. W. Osler (Ed.).
91. Pecora N.D., Gehring A.J., Canaday D.H., Boom W.H., Harding C.V. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. J. Immunol. 2006, 177:422-429.
92. Pereira A.C., Brito-de-Souza V.N., Cardoso C.C., Dias-Baptista I.M., Parelli F.P., Venturini J., Villani-Moreno F.R., Pacheco A.G., Moraes M.O. Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility. Genes Immun. 2009, 10:174-180.
93. Peyron P., Bordier C., N'Diaye E.N., Maridonneau-Parini I. Nonopsonic phagocytosis of Mycobacterium kansasii by human neutrophils depends on cholesterol and is mediated by CR3 associated with glycosylphosphatidylinositol-anchored proteins. J. Immunol. 2000, 165:5186-5191.
94. Prado-Montes de O.E., Velarde-Felix J.S., Rios-Tostado J.J., Picos-Cardenas V.J., Figuera L.E. SNP 668C (-44) alters a NF-kappaB1 putative binding site in non-coding strand of human beta-defensin 1 (DEFB1) and is associated with lepromatous leprosy. Infect. Genet. Evol. 2009, 9:617-625.
95. Reed M.B., Domenech P., Manca C., Su H., Barczak A.K., Kreiswirth B.N., Kaplan G., Barry C.E. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004, 431:84-87.
96. Ridley D.S., Jopling W.H. Classification of leprosy according to immunity. A five-group system. Int. J. Lepr. 1966, 34:255-273.
97. Ridley D.S., Ridley M.J. Rationale for the histological spectrum of tuberculosis. A basis for classification. Pathology 1987, 19:186-192.
98. Ridley M.J., Ridley D.S., De Beer F.C., Pepys M.B. C-reactive protein and apoB containing lipoproteins are associated with Mycobacterium leprae in lesions of human leprosy. Clin. Exp. Immunol. 1984, 56:545-552.
99. Roy S., Frodsham A., Saha B., Hazra S.K., Mascie-Taylor C.G., Hill A.V. Association of vitamin D receptor genotype with leprosy type. J. Infect. Dis. 1999, 179:187-191.
100. Sakurai I., Skinsnes O.K. Lipids in leprosy. 2. Histochemistry of lipids in human leprosy. Int. J. Lepr. Other Mycobact. Dis. 1970, 38:389-403.
101. Salgame P., Abrams J.S., Clayberger C., Goldstein H., Convit J., Modlin R.L., Bloom B.R. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991, 254:279-282.
102. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994, 179:1109-1118.
103. Santos A.R., Suffys P.N., Vanderborght P.R., Moraes M.O., Vieira L.M., Cabello P.H., Bakker A.M., Matos H.J., Huizinga T.W., Ottenhoff T.H., Sampaio E.P., Sarno E.N. Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy. J. Infect. Dis. 2002, 186:1687-1691.
104. Santos D.O., Castro H.C., Bourguignon S.C., Bastos O.M., Rodrigues C.R., Van H.H., Nery J.A., Miranda A. Expression of B7-1 costimulatory molecules in patients with multibacillary leprosy and reactional states. Clin. Exp. Dermatol. 2007, 32:75-80.
105. Schlesinger L.S. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 1993, 150:2920-2930.
106. Schroder N.W., Hermann C., Hamann L., Gobel U.B., Hartung T., Schumann R.R. High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J. Mol. Med. 2003, 81:368-372.
107. Schuring R.P., Hamann L., Faber W.R., Pahan D., Richardus J.H., Schumann R.R., Oskam L. Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions. J. Infect. Dis. 2009, 199:1816-1819.
108. Sieling P.A., Wang X.-H., Gately M.K., Oliveros J.L., McHugh T., Barnes P.F., Wolf S.F., Golkar L., Yamamura M., Yogi Y., Uyemura K., Rea T.H., et al. IL-12 regulates T helper Type 1 cytokine responses in human infectious disease. J. Immunol. 1994, 153:3639-3647.
109. Sieling P.A., Chatterjee D., Porcelli S.A., Prigozy T.I., Soriano T., Brenner M.B., Kronenberg M., Brennan P.J., Modlin R.L. CD1-restricted T cell recognition of microbial lipoglycans. Science 1995, 269:227-230.
110. Sieling P.A., Jullien D., Dahlem M., Tedder T.F., Rea T.H., Modlin R.L., Porcelli S.A. CD1 expression by dendritic cells in human leprosy lesions: Correlation with effective host immunity. J. Immunol. 1999, 162:1851-1858.
111. Sieling P.A., Hill P.J., Dobos K.M., Brookman K., Kuhlman A.M., Fabri M., Krutzik S.R., Rea T.H., Heaslip D.G., Belisle J.T., Modlin R.L. Conserved mycobacterial lipoglycoproteins activate TLR2 but also require glycosylation for MHC class II-restricted T cell activation. J. Immunol. 2008, 180:5833-5842.
112. Simoes Quaresma J.A., de Oliveira M.F., Ribeiro Guimaraes A.C., de Brito E.B., de Brito R.B., Pagliari C., de Brito A.C., Xavier M.B., Seixas Duarte M.I. CD1a and factor XIIIa immunohistochemistry in leprosy: A possible role of dendritic cells in the pathogenesis of Mycobacterium leprae infection. Am. J. Dermatopathol. 2009, 31:527-531.
113. Soilleux E.J., Morris L.S., Leslie G., Chehimi J., Luo Q., Levroney E., Trowsdale J., Montaner L.J., Doms R.W., Weissman D., Coleman N., Lee B. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J. Leukoc. Biol. 2002, 71:445-457.
114. Stenger S., Mazzaccaro R.J., Uyemura K., Cho S., Barnes P.F., Rosat J.P., Sette A., Brenner M.B., Porcelli S.A., Bloom B.R., Modlin R.L. Differential effects of cytolytic T cell subsets on intracellular infection. Science 1997, 276:1684-1687.
115. Suzuki K., Takeshita F., Nakata N., Ishii N., Makino M. Localization of CORO1A in the macrophages containing Mycobacterium leprae. Acta Histochem. Cytochem. 2006, 39:107-112.
116. Takeuchi O., Kawai T., Muhlradt P.F., Morr M., Radolf J.D., Zychlinsky A., Takeda K., Akira S. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 2001, 13:933-940.
117. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., Modlin R.L., Akira S. Role of TLR1 in mediating immune response to microbial lipoproteins. J. Immunol. 2002, 169:10-14.
118. Tanigawa K., Suzuki K., Nakamura K., Akama T., Kawashima A., Wu H., Hayashi M., Takahashi S., Ikuyama S., Ito T., Ishii N. Expression of adipose differentiation-related protein (ADRP) and perilipin in macrophages infected with Mycobacterium leprae. FEMS Microbiol. Lett. 2008, 289:72-79.
119. Tanigawa K., Suzuki K., Kimura H., Takeshita F., Wu H., Akama T., Kawashima A., Ishii N. Tryptophan aspartate-containing coat protein (CORO1A) suppresses Toll-like receptor signalling in Mycobacterium leprae infection. Clin. Exp. Immunol. 2009, 156:495-501.
120. Thoma-Uszynski S., Stenger S., Takeuchi O., Ochoa M.T., Engele M., Sieling P.A., Barnes P.F., Rollinghoff M., Bolcskei P.L., Wagner M., Akira S., Norgard M.V., et al. Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science 2001, 291:1544-1547.
121. Van den Heuvel M.M., Tensen C.P., van As J.H., Van den Berg T.K., Fluitsma D.M., Dijkstra C.D., Dopp E.A., Droste A., Van Gaalen F.A., Sorg C., Hogger P., Beelen R.H. Regulation of CD 163 on human macrophages: Cross-linking of CD163 induces signaling and activation. J. Leukoc. Biol. 1999, 66:858-866.
122. Vergne I., Chua J., Deretic V. Tuberculosis toxin blocking phagosome maturation inhibits a novel Ca2+/calmodulin-PI3K hVPS34 cascade. J. Exp. Med. 2003, 198:653-659.
123. Vergne I., Chua J., Lee H.H., Lucas M., Belisle J., Deretic V. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 2005, 102:4033-4038.
124. Virchow R. Die krankhaften Geschwülste 1863, August Hirschwald, Berlin.
125. Wang T.T., Nestel F.P., Bourdeau V., Nagai Y., Wang Q., Liao J., Tavera-Mendoza L., Lin R., Hanrahan J.W., Mader S., White J.H. Cutting edge: 1,25-Dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 2004, 173:2909-2912.
126. Wilkinson R.J., Llewelyn M., Toossi Z., Patel P., Pasvol G., Lalvani A., Wright D., Latif M., Davidson R.N. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: A case-control study. Lancet 2000, 355:618-621.
127. Yamamura M., Uyemura K., Deans R.J., Weinberg K., Rea T.H., Bloom B.R., Modlin R.L. Defining protective responses to pathogens: Cytokine profiles in leprosy lesions. Science 1991, 254:277-279.
128. Yamamura M., Wang X.-H., Ohmen J.D., Uyemura K., Rea T.H., Bloom B.R., Modlin R.L. Cytokine patterns of immunologically mediated tissue damage. J. Immunol. 1992, 149:1470-1475.
129. Yamashita Y., Maeda Y., Takeshita F., Brennan P.J., Makino M. Role of the polypeptide region of a 33 kDa mycobacterial lipoprotein for efficient IL-12 production. Cell. Immunol. 2004, 229:13-20.
130. Yang Y., Yin C., Pandey A., Abbott D., Sassetti C., Kelliher M.A. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J. Biol. Chem. 2007, 282:36223-36229.
131. Yeung T., Grinstein S. Lipid signaling and the modulation of surface charge during phagocytosis. Immunol. Rev. 2007, 219:17-36.
132. Yuk J.M., Shin D.M., Lee H.M., Yang C.S., Jin H.S., Kim K.K., Lee Z.W., Lee S.H., Kim J.M., Jo E.K. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009, 6:231-243.
133. Zaba L.C., Fuentes-Duculan J., Steinman R.M., Krueger J.G., Lowes M.A. Normal human dermis contains distinct populations of CD11cBDCA-1 dendritic cells and CD163FXIIIA macrophages. J. Clin. Invest. 2007, 117:2517-2525.
134. Zeyda M., Stulnig T.M. Adipose tissue macrophages. Immunol. Lett. 2007, 112:61-67.
135. Zhang F.R., Huang W., Chen S.M., Sun L.D., Liu H., Li Y., Cui Y., Yan X.X., Yang H.T., Yang R.D., Chu T.S., Zhang C., et al. Genomewide association study of leprosy. N. Engl. J. Med. 2009, 361:2609-2618.